Меню
Идёт набор NCT05663242

The Effects of Using Different Anesthetics on the Prognosis of Primary Lung Tumors and Its Mechanism of Action

Фаза IV С лечением Lung Cancer Progression, Disease Anesthesia

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
В протоколе указаны: Propofol, Sevoflurane.
Кому может быть актуально
Состояния в реестре: Lung Cancer, Progression, Disease, Anesthesia. Базовые параметры: 20 лет — 80 лет · Все.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
Тайвань
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →

Не всё понятно в терминах? Прочитайте наш гид для пациентов →

Официальное название

To Compare the Effects of Intraoperative Use of Intravenous Anesthetics Propofol and Inhaled Anesthetics Sevoflurane on the Prognosis of Patients Undergoing Surgery for Primary Lung Tumors and the Investigation of Its Mechanism of Action.

Обзор

This is a two-arm, parallel-group randomized clinical trial. Routine perioperative care would be performed in volunteers with primary early lung cancer. The study will enroll approximately 300 volunteers to compare the progression-free or overall survival in patients undergoing video-assisted thoracoscopic surgery (VATS) for primary lung tumors between propofol and sevoflurane for the maintenance of anesthesia.

Подробное описание

Before the scheduled procedure, the patients are randomly assigned into peopofol group or groups (1:1) according to the randomization generated by the computer. Both groups were induced with propofol 1\~2.5 mg/kg propofol. The propofol group was maintained at an effect-site concentration of 2.0-4.0 mcg/mL by a target-controlled infusion system. The sevoflurane group was maintained via sevoflurane vaporizer between 1% and 3% (target minimum alveolar concentration of 0.7-1.3 MAC). During the operation, the dose of anesthetic drugs (propofol/fentanyl /remifentanil and sevoflurane/cisatracurium/rocuronium) are adjusted to maintain the mean arterial pressure and heartbeat fluctuations within 20% of the baseline value and Entropy (or BIS) value at 40-60in both groups. The following patient data were recorded, the type of anesthesia, sex, age at the time of surgery, preoperative Karnofsky performance status score and functional capacity, the postoperative complications within 30 days (according Clavien-Dindo classification), American Society of Anesthesiologists physical status scores, tumor size, intraoperative blood loss/transfusion, duration of surgery, duration of anesthesia, total opioid (remifentanil/fentanyl/ propofol) use, postoperative radiation therapy, postoperative chemotherapy, postoperative concurrent chemoradiotherapy, the presence of disease progression, and 6-month, 1-year, and 3-year overall survival and Karnofsky performance status score were recorded.

Вмешательства

  • Препарат Propofol
    The propofol group was both induced and maintained at an effect-site concentration (Ce) of 2.0-4.0 mcg/mL by a target-controlled infusion (TCI) system.
  • Препарат Sevoflurane
    The sevoflurane group was maintained via sevoflurane vaporizer between 1% and 3% (target minimum alveolar concentration of 0.7-1.3 MAC)

Первичные конечные точки

  • Overall survival [Срок оценки: From the date of surgery until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 36 months]
  • The presence of disease progression [Срок оценки: From the date of surgery until the date of first documented progression (recurrence or metastasis),assessed up to 36 months]
Вторичные конечные точки (3)
  • Postoperative complications [Срок оценки: The period from the day of surgery to postoperative 30 days]
  • Karnofsky performance status score [Срок оценки: Karnofsky performance score(from 0 (dead) to 100(normal no complication)) before surgery (baseline data) , postoperation 7 days, postoperation 3 months, postoperation 6 months, postoperation 12 months]
  • Length of hospital stays [Срок оценки: from the day of surgery to dischage, assessed up to 30 days]

Критерии участия

Критерии включения

  • eighteen to eighty-year-old
  • ASA class I-III patients
  • Received elective thoracic surgery for primary lung tumors under general anesthesia

Критерии исключения

  • mental disorder
  • poor liver function
  • pregnant or lactating women
  • morbidly obese
  • allergy to any of the drugs used in this study
  • recurrent tumor or repeat surgery
  • biopsy cases
  • incomplete outcome-data
  • palliative treatment after surgery
  • simultaneous treatment of other malignancies
  • emergency surgery
  • presence of other malignant tumors
  • combined propofol and inhalation anesthesia or other anesthetics, such as ketamine or dexmedetomidine
  • diagnosed as benign lung tumor, or other metastatic lung tumor

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Распределение
Рандомизированное
Модель
Параллельные группы
Маскирование
Двойное слепое
Основная цель
Лечение

Центры проведения

Тайвань · 1 центр
  • Kaohsiung Medical University Chung-Ho Memorial Hospital — Kaohsiung City

Идентификаторы

NCT: NCT05663242 · KMUHIRB-F(I)-20210218.

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗